Skip to content

Clinical trials

Candidiasis, Vulvovaginal trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Candidiasis, Vulvovaginal Country / region: United States Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20112
20134
20141
20151
20164
20172
20182
20195
20222
20232
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting3
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Scynexis, Inc.7
Mycovia Pharmaceuticals Inc.3
National Institute of Allergy and Infectious Diseases (NIAID)3
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2
Matinas BioPharma Nanotechnologies, Inc.2
Viamet2
Agency for Healthcare Research and Quality (AHRQ)1
Coologics, Inc1
Hoffmann-La Roche1
MethylGene Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Candidiasis, Vulvovaginal33
Vaginosis, Bacterial8
Vaginitis5
Candidiasis4
Mycoses3
Trichomonas Infections2
Trichomonas Vaginitis2
Vulvovaginitis2
Aspergillosis, Allergic Bronchopulmonary1
Blastomycosis1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.